Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Alirocumab> ?p ?o }
Showing triples 1 to 95 of
95
with 100 triples per page.
- Alirocumab abstract "Alirocumab (trade name Praluent) is a biopharmaceutical drug approved by the FDA on July 24, 2015 as a second line treatment for high cholesterol for adults whose cholesterol is not controlled by diet and statin treatment. It is a human monoclonal antibody that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors, and it was the first such agent to receive FDA approval. The FDA approval was contingent on the completion of further clinical trials to better determine efficacy and safety.".
- Alirocumab atcPrefix "none".
- Alirocumab casNumber "1245916-14-6".
- Alirocumab wikiPageExternalLink praluent.pdf.
- Alirocumab wikiPageExternalLink www.praluent.com.
- Alirocumab wikiPageID "35800673".
- Alirocumab wikiPageLength "15765".
- Alirocumab wikiPageOutDegree "61".
- Alirocumab wikiPageRevisionID "707381603".
- Alirocumab wikiPageWikiLink Amgen.
- Alirocumab wikiPageWikiLink Apheresis.
- Alirocumab wikiPageWikiLink Atherosclerosis.
- Alirocumab wikiPageWikiLink BioMarin_Pharmaceutical.
- Alirocumab wikiPageWikiLink Biological_target.
- Alirocumab wikiPageWikiLink Biopharmaceutical.
- Alirocumab wikiPageWikiLink CVS_Health.
- Alirocumab wikiPageWikiLink Cardiovascular_disease.
- Alirocumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Alirocumab wikiPageWikiLink Category:PCSK9_inhibitor.
- Alirocumab wikiPageWikiLink Chinese_hamster_ovary_cell.
- Alirocumab wikiPageWikiLink Clinical_trial.
- Alirocumab wikiPageWikiLink Dialysis.
- Alirocumab wikiPageWikiLink Disulfide.
- Alirocumab wikiPageWikiLink Drug_discovery.
- Alirocumab wikiPageWikiLink Express_Scripts.
- Alirocumab wikiPageWikiLink Familial_hypercholesterolemia.
- Alirocumab wikiPageWikiLink Fetus.
- Alirocumab wikiPageWikiLink Food_and_Drug_Administration.
- Alirocumab wikiPageWikiLink Hypercholesterolemia.
- Alirocumab wikiPageWikiLink Immunoglobulin_G.
- Alirocumab wikiPageWikiLink Immunoglobulin_heavy_chain.
- Alirocumab wikiPageWikiLink Immunoglobulin_light_chain.
- Alirocumab wikiPageWikiLink Industrial_fermentation.
- Alirocumab wikiPageWikiLink International_nonproprietary_name.
- Alirocumab wikiPageWikiLink Investigational_New_Drug.
- Alirocumab wikiPageWikiLink LDL_receptor.
- Alirocumab wikiPageWikiLink Low-density_lipoprotein.
- Alirocumab wikiPageWikiLink Monoclonal_antibody.
- Alirocumab wikiPageWikiLink PCSK9.
- Alirocumab wikiPageWikiLink Pharmacy_benefit_management.
- Alirocumab wikiPageWikiLink Placebo.
- Alirocumab wikiPageWikiLink Priority_review_voucher.
- Alirocumab wikiPageWikiLink Proteolysis.
- Alirocumab wikiPageWikiLink Recombinant_DNA.
- Alirocumab wikiPageWikiLink Regeneron.
- Alirocumab wikiPageWikiLink Sanofi.
- Alirocumab wikiPageWikiLink Statin.
- Alirocumab wikiPageWikiLink Subcutaneous_injection.
- Alirocumab wikiPageWikiLink The_New_England_Journal_of_Medicine.
- Alirocumab wikiPageWikiLink Therapy.
- Alirocumab wikiPageWikiLinkText "Alirocumab".
- Alirocumab wikiPageWikiLinkText "alirocumab".
- Alirocumab atcPrefix "none".
- Alirocumab c "6472".
- Alirocumab casNumber "1245916".
- Alirocumab chemspiderid "none".
- Alirocumab h "9996".
- Alirocumab legalStatus "FDA approved".
- Alirocumab mabType "mab".
- Alirocumab molecularWeight "146".
- Alirocumab n "1736".
- Alirocumab o "2032".
- Alirocumab routesOfAdministration Subcutaneous_injection.
- Alirocumab s "42".
- Alirocumab source "u".
- Alirocumab target "Proprotein convertase subtilisin/kexin type 9".
- Alirocumab tradename "Praluent".
- Alirocumab type "mab".
- Alirocumab wikiPageUsesTemplate Template:Drugbox.
- Alirocumab wikiPageUsesTemplate Template:Main.
- Alirocumab wikiPageUsesTemplate Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems.
- Alirocumab wikiPageUsesTemplate Template:Reflist.
- Alirocumab wikiPageUsesTemplate Template:Rp.
- Alirocumab subject Category:Monoclonal_antibodies.
- Alirocumab subject Category:PCSK9_inhibitor.
- Alirocumab hypernym Drug.
- Alirocumab type ChemicalSubstance.
- Alirocumab type Drug.
- Alirocumab type Antibody.
- Alirocumab type Chemical.
- Alirocumab type Drug.
- Alirocumab type ChemicalObject.
- Alirocumab type Thing.
- Alirocumab type Q8386.
- Alirocumab comment "Alirocumab (trade name Praluent) is a biopharmaceutical drug approved by the FDA on July 24, 2015 as a second line treatment for high cholesterol for adults whose cholesterol is not controlled by diet and statin treatment. It is a human monoclonal antibody that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors, and it was the first such agent to receive FDA approval.".
- Alirocumab label "Alirocumab".
- Alirocumab sameAs Q4726914.
- Alirocumab sameAs أليروكوماب.
- Alirocumab sameAs Alirocumab.
- Alirocumab sameAs Alirocumab.
- Alirocumab sameAs Alirocumab.
- Alirocumab sameAs m.0js_wl_.
- Alirocumab sameAs Q4726914.
- Alirocumab wasDerivedFrom Alirocumab?oldid=707381603.
- Alirocumab isPrimaryTopicOf Alirocumab.